Trial Profile
Excel Drug-Eluting Stent Pilot Clinical Registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2013
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Antiplatelets
- Indications Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis; Embolism and thrombosis
- Focus Therapeutic Use
- 27 Apr 2013 New trial record